These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33857857)

  • 1. DNA methylation and protein expression of Wnt pathway markers in progressive glioblastoma.
    Tompa M; Kajtar B; Galik B; Gyenesei A; Kalman B
    Pathol Res Pract; 2021 Jun; 222():153429. PubMed ID: 33857857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt pathway markers in molecular subgroups of glioblastoma.
    Tompa M; Nagy A; Komoly S; Kalman B
    Brain Res; 2019 Sep; 1718():114-125. PubMed ID: 31075260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the Catecholamine Pathway in Glioblastoma Development.
    Kraboth Z; Kajtár B; Gálik B; Gyenesei A; Miseta A; Kalman B
    Cells; 2021 Mar; 10(3):. PubMed ID: 33806345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt/β-catenin pathway and COX-2/PGE2/EP4 signaling in glioblastoma cells.
    Majchrzak-Celińska A; Misiorek JO; Kruhlenia N; Przybyl L; Kleszcz R; Rolle K; Krajka-Kuźniak V
    BMC Cancer; 2021 May; 21(1):493. PubMed ID: 33941107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GOLM1 silencing inhibits the proliferation and motility of human glioblastoma cells via the Wnt/β-catenin signaling pathway.
    Ding X; Deng G; Liu J; Liu B; Yuan F; Yang X; Chen Q
    Brain Res; 2019 Aug; 1717():117-126. PubMed ID: 30935831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GBM-Derived Wnt3a Induces M2-Like Phenotype in Microglial Cells Through Wnt/β-Catenin Signaling.
    Matias D; Dubois LG; Pontes B; Rosário L; Ferrer VP; Balça-Silva J; Fonseca ACC; Macharia LW; Romão L; E Spohr TCLS; Chimelli L; Filho PN; Lopes MC; Abreu JG; Lima FRS; Moura-Neto V
    Mol Neurobiol; 2019 Feb; 56(2):1517-1530. PubMed ID: 29948952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPCAL1 promotes glioblastoma proliferation via activation of Wnt/β-catenin signalling pathway.
    Zhang D; Liu X; Xu X; Xu J; Yi Z; Shan B; Liu B
    J Cell Mol Med; 2019 May; 23(5):3108-3117. PubMed ID: 30843345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA Methylation in Recurrent Glioblastomas: Increased TEM8 Expression Activates the Src/PI3K/AKT/GSK-3β/B-Catenin Pathway.
    Kundu P; Jain R; Kanuri NN; Arimappamagan A; Santosh V; Kondaiah P
    Cancer Genomics Proteomics; 2024; 21(5):485-501. PubMed ID: 39191501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory role of miRNAs on Wnt/β-catenin signaling in tumorigenesis of glioblastoma.
    Rahmani F; Hashemian P; Tabrizi AT; Ghorbani Z; Ziaeemehr A; Alijannejad S; Ferns GA; Avan A; Shahidsales S
    Indian J Cancer; 2023; 60(3):295-302. PubMed ID: 37787188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt/β-catenin signaling in glioblastoma.
    Lan F; Pan Q; Yu H; Yue X
    J Neurochem; 2015 Sep; 134(5):811-8. PubMed ID: 25991372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt3a mediated activation of Wnt/β-catenin signaling promotes tumor progression in glioblastoma.
    Kaur N; Chettiar S; Rathod S; Rath P; Muzumdar D; Shaikh ML; Shiras A
    Mol Cell Neurosci; 2013 May; 54():44-57. PubMed ID: 23337036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt-Induced Stabilization of KDM4C Is Required for Wnt/β-Catenin Target Gene Expression and Glioblastoma Tumorigenesis.
    Chen Y; Fang R; Yue C; Chang G; Li P; Guo Q; Wang J; Zhou A; Zhang S; Fuller GN; Shi X; Huang S
    Cancer Res; 2020 Mar; 80(5):1049-1063. PubMed ID: 31888886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of carbohydrate sulfotransferase 12 decreases the proliferation and mobility of glioblastoma cells via the WNT/β-catenin pathway.
    Wang J; Xia X; Tao X; Zhao P; Deng C
    Bioengineered; 2021 Dec; 12(1):3934-3946. PubMed ID: 34288811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASPM promotes glioblastoma growth by regulating G1 restriction point progression and Wnt-β-catenin signaling.
    Chen X; Huang L; Yang Y; Chen S; Sun J; Ma C; Xie J; Song Y; Yang J
    Aging (Albany NY); 2020 Jan; 12(1):224-241. PubMed ID: 31905171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
    Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
    Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteins of the Wnt signaling pathway as targets for the regulation of CD133+ cancer stem cells in glioblastoma.
    Shevchenko V; Arnotskaya N; Korneyko M; Zaytsev S; Khotimchenko Y; Sharma H; Bryukhovetskiy I
    Oncol Rep; 2019 May; 41(5):3080-3088. PubMed ID: 30864699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sohlh1 suppresses glioblastoma cell proliferation, migration, and invasion by inhibition of Wnt/β-catenin signaling.
    Liu X; Gao Q; Zhao N; Zhang X; Cui W; Sun J; Fu J; Hao J
    Mol Carcinog; 2018 Apr; 57(4):494-502. PubMed ID: 29240260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells.
    Kim KH; Seol HJ; Kim EH; Rheey J; Jin HJ; Lee Y; Joo KM; Lee J; Nam DH
    Neuro Oncol; 2013 Feb; 15(2):161-71. PubMed ID: 23258844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Catenin-dependent pathway activation by both promiscuous "canonical" WNT3a-, and specific "noncanonical" WNT4- and WNT5a-FZD receptor combinations with strong differences in LRP5 and LRP6 dependency.
    Ring L; Neth P; Weber C; Steffens S; Faussner A
    Cell Signal; 2014 Feb; 26(2):260-7. PubMed ID: 24269653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.